Diabetes Information
 
Web World-SuperSite

Benfotiamine - A New Tool In Preventing Diabetic Complications?


Benfotiamine made headlines globally in 2003 when researchers released information about a study that was conducted at The Einstein College of Medicine in New York. The bottom line of this study was that a substance of the allithiamine group of the naturally occurring thiamine-derived compounds had positive effects on neuropathy, retinopathy and nephropathy and heart/circulatory problems in diabetics.

Benfotiamine research has suggested that there are beneficial effects for diabetics and non-diabetics also. These benefits include sciatica, vascular health, general nerve health, lower blood pressure, grant cellular protection, anti-aging, fibromyalgia, prevention of lactic acidosis, and treatment for Alzheimer's disease. Any condition that is the result of a thiamine deficiency will also respond quite well to benfotiamine. Of course, any bodily function that is improved by a therapeutic level of thiamine will certainly be enhanced by benfotiamine, since benfotiamine is perhaps the most effective form of thiamine.

Benfotiamine, a derivative of thiamine (vitamin B1), was an invention of Japanese scientists and there is a U.S. patent on benfotiamine that was entered by the Japanese back in 1962. Japanese benfotiamine is considered the purest source of bulk benfotiamine and is favored by manufacturers globally who insist on the highest quality in their benfotiamine product.

The safety of benfotiamine use has been proven over 12 years of use in Europe for the treatment and prevention of diabetic complications among others. The original Japanese patent on benfotiamine gave information that it is even less toxic than common vitamin B1 (thiamine hydrochloride usually). Orally ingested vitamin B1 has a long history of use as an oral supplement without reported adverse effects. Due to its therapeutic action in some frequently observed clinical syndromes, thiamine hydrochloride has been advised and used over a long period of time. There are no reports of adverse effects of oral thiamine, even at dosages of several hundred milligrams a day (SCOGS, 1978; DHEW, 1979; Marks, 1989).

Benfotiamine has a very good safety record. To date, there has been no reports of any known, negative interactions with any medications. To the contrary, some medications actually can cause a thiamine deficiency in some people and benfotiamine could correct this serious situation.

Many researchers, medical experts, doctors, podiatrists and many medical publishers recommend benfotiamine for neuropathy, retinopathy nephropathy, heart/circulatory complications and B1 deficiencies. Any in depth study on the web will produce physicians, naturopaths, neurologists, optometrists, chiropractors, etc. who have very positive feelings about the effectiveness and potential of benfotiamine in terms of the research done to date on this important tool in the arsenal against neuropathy, retinopathy and beneficial for the heart and circulatory system. We have professional healthcare providers from all of these disciplines which shows the confidence the medical community has in the purity and bioavailability of our benfotiamine product.

Dr. David Williams, publisher of "Alternatives Newsletter", wrote an in depth article concerning benfotiamine in his May, 2004 issue. This article is an eye opener in terms of how effective benfotiamine can be for many health conditions. If possible, it would be beneficial for any interested reader to take a look at this article. For more information about this article you may contact the author below.

Dr Paul Chous is another medical professional who sees the merits of benfotiamine:

"I suspect strongly that benfotiamine will mitigate (or, hopefully, prevent) DRT in humans, but the burden of proof has not yet been met. The case for symptomatic relief of neuropathy symptoms is, of course, more tangible." http://www.emuhealthproducts.com/drchous.html

In conclusion, the consensus for benfotiamine is very positive and are worth investigating. If you or anyone you know is a diabetic, the great possibility of developing diabetic complications over time makes benfotiamine a viable tool in the arsenal for protection. If they are already experiencing complications such as neuropathy, retinopathy, and others, they will benefit from possible reduction in the progression along with pain relief in terms of peripheral neuropathy and other neuropathies.

Zach Malott is CEO of Brentwood Health International, a nutritional supplement company involved in distribution and supplying wholesale, retail and end users.

Mr. Malott is available to discuss the research as it applies to benfotiamine in the treatment and prevention of diabetic complications such as neuropathy and retinopathy.

He can be reached at:

Phone: 505.354.0526

Website: http://www.emuhealthproducts.com


MORE RESOURCES:

dBTechno

Genetic Screening for Diabetes No More Useful than Traditional Methods
eFluxMedia - 1 hour ago
By Anna Boyd Genetic testing to see someone’s predisposition to type 2 diabetes is not significantly better than an assessment based on traditional risk ...
Genetic Screening May ID Diabetes Risk WebMD
Egg consumption may raise risk of type 2 diabetes Food Consumer
Gene testing for diabetes risk is not useful Los Angeles Times
That Happened! - Melbourne Herald Sun
all 53 news articles


Type 2 diabetes may slow mental processing speed
Reuters - 19 hours ago
NEW YORK (Reuters Health) - New research shows that among the mental abilities that are affected by type 2 diabetes, the speed at which the brain processes ...
THE COST OF DIABETES National Center for Policy Analysis
THE ASSOCIATED PRESS Hartford Courant
all 8 news articles


Initial Survey Findings on Diabetes Awareness Released by ...
MarketWatch - 7 hours ago
BATON ROUGE, La., Nov 21, 2008 (BUSINESS WIRE) -- Patient Assistance releases initial findings of a survey on diabetes awareness amongst the predominantly ...


WCBD

Millions have diabetes and don’t know it. How about you?
WCBD, SC - 3 hours ago
November is diabetes awareness month and it’s estimated more than five million people in the US are unaware that they have it. 23-million Americans have ...


Los Angeles Times

Health of California's seniors is deteriorating
Los Angeles Times, CA - 7 hours ago
A recent UCLA medical study has found that a growing number of older Californians are suffering from chronic conditions such as diabetes and hypertension. ...
Valley seniors' health woes rise Fresno Bee
San Joaquin Valley center of emerging health crisis among elderly UC Los Angeles
all 5 news articles


Cherokees mark November as Diabetes Awareness Month
Muskogee Daily Phoenix, OK - 10 hours ago
TAHLEQUAH — Diabetes has reached epidemic proportions among Native Americans, and complications from diabetes are major causes of death and health problems ...
Vinita to celebrate Indian Territory Day Cherokee Phoenix
Celebrate Thanksgiving the Cherokee Way Cherokee Phoenix
all 3 news articles


Mt. View student fights for life after onset of diabetes
Kennebec Journal, ME - 9 hours ago
Relatives say Justin Hewins, 16, of Troy, is suffering from brain damage following a sudden onset of diabetes. For the past two weeks, Hewins has been a ...


Advanced Health Care Options for People With Diabetes
Extra Newspaper, IL - 19 hours ago
20 /PRNewswire-HISPANIC PR WIRE/ -- It's estimated that almost 2.5 million Latinos in the US will be affected by diabetes by 2020, of those, ...


Diabetes on the rise nationally and in northwest Ohio
Defiance Crescent News, OH - 19 hours ago
By DARLENE PRINCE Wherever you look for answers, the conclusion is the same: The incidence of diabetes is on the rise, both nationally and in the northwest ...
Two area senior citizens, one teen deal with their diabetes with ... Defiance Crescent News
all 2 news articles


Garlic-Based Drug May Cure Diabetes
WAPT, MS - Nov 20, 2008
A drug based on a chemical found in garlic can treat diabetes types I and II when taken as a tablet, according to a new study. The drug was tested on mice ...

Diabetes - Google News

home | site map
© 2006